vaccination to prevent anal cancer due to human papillomavirus
Anal cancer is a relatively rare yet increasingly prevalent malignancy, with human papillomavirus (HPV) infection recognized as the primary etiological factor. Over 90% of anal cancer cases are associated with persistent infection by high-risk HPV types, particularly HPV-16 and HPV-18. The virus infects the squamous epithelium of the anal canal, where it may induce cellular